Category Archives: ClinAccel.Net

Replicor announces publication of the REP 401 study achieving high rates of virologic control and functional cure in patients with chronic hepatitis B infection

Below, we are re-publishing with permission the press-release issued by Replicor Inc. on March 09, 2020 MONTREAL, March 9, 2020 – Replicor Inc., a privately held biopharmaceutical company targeting functional cure for patients with chronic hepatitis B and D infection, … Continue reading

Posted in Biotech, Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator | Leave a comment

Clinical Accelerator and BetaGlue Technologies to conduct First in Human Medical Device Investigations in Breast Cancer and Liver Cancer

Clinical Accelerator is pleased to announce an exciting new collaboration with BetaGlue Technologies SpA. Two studies will be conducted, one on radio-ablation of surgical margins following resection of breast ductal carcinoma in situ (DCIS), in 20 patients and one of … Continue reading

Posted in Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator, Medical Devices | Leave a comment

The effects of the New FDA Rule for medical device investigations conducted outside the United States

  On February 21, 2019 the new US FDA rule on medical device clinical investigations conducted outside the United States (OUS) became effective. In this post, we would like to discuss the difference between the old and the new regulation and … Continue reading

Posted in ClinAccel.Net, Clinical Accelerator, FDA, Medical Devices, Regulations | Leave a comment

The ongoing search for the better early-stage clinical trial location: a case study on Australia and Georgia

International biotech and medtech companies are constantly searching for optimal locations for their early stage and proof-of-concept clinical trials. An example of a location that has become increasingly popular is Australia. This is in large part due to the great … Continue reading

Posted in Biotech, Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator, FDA, Medical Devices, Patient Enrolment | Leave a comment

Clinical Accelerator announces collaboration with Reprieve Cardiovascular for developing a Cardiovascular system to treat Acute Decompensated Heart Failure

Clinical Accelerator, a full-service contract research organization, is pleased to announce that it has entered into a collaboration with Reprieve Cardiovascular, LLC for conducting a study aimed at optimally decongesting patients with Acute Decompensated Heart Failure (ADHF). The study will … Continue reading

Posted in Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator, Medical Devices | Leave a comment

Clinical Accelerator collaborates with Thrombolytic Science International to study a tPA/mutant pro-urokinase dual regimen for thrombolysis in acute myocardial infarction

Clinical Accelerator, a full-service contract research organization, has entered into a collaboration with Thrombolytic Science International (TSI) to conduct a phase II randomised, multi-centre, open-label, parallel group mechanistic study using TSI’s dual treatment regimen in patients with ST elevation myocardial … Continue reading

Posted in Biotech, Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator | Leave a comment

VisCardia Announces Completion of Enrollment and Three Month Follow-Up Visits for Its VisONE® Heart Failure Pilot Study

Below, we are re-publishing with permission the press-release issued by VisCardia Inc. on April 22, 2019 PORTLAND, Ore.–(BUSINESS WIRE)–VisCardia Inc., a privately held medical device developer, announced today it has completed enrollment and three month follow-up visits of the company’s … Continue reading

Posted in Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator, Medical Devices | Leave a comment

Clinical Accelerator announces collaboration with Archivel Farma in a phase IIa Clinical Trial for RUTI®: a therapeutic vaccination against Multi-Drug Resistant Tuberculosis

Clinical Accelerator, a full-service contract research organization, is pleased to announce that it has entered into a collaboration with Archivel Farma, for conducting a phase IIa clinical trial for their therapeutic vaccine RUTI® against multi-drug Resistant tuberculosis. The double-blind, randomized … Continue reading

Posted in Biotech, Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator | Leave a comment

The World’s First VisONE® Implantation: a promising start

Below, we are re-publishing with permission the press-release issued by the Heart Institute on the 28th of September 2018 “Thanks to the efforts of the study team from the Heart Institute, we have conducted the first worldwide implantation of the VisONE … Continue reading

Posted in Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator, Medical Devices | Leave a comment

FDA inspections produce solid evidence of high quality clinical trial data originating in Central and Eastern Europe

Clinical Accelerator is a clinical CRO with a special focus on Central and Eastern Europe currently operating in 11 countries of that region: Bulgaria, Estonia, Georgia, Hungary, Latvia, Lithuania, Moldova, Poland, Romania, Russian Federation, and the Ukraine (listed alphabetically). The … Continue reading

Posted in Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator, FDA | Leave a comment